Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2006
09/27/2006CN1838964A Treatment and prevention of pulmonary conditions
09/27/2006CN1838958A Methods of treating COPD and pulmonary hypertension
09/27/2006CN1838953A 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
09/27/2006CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
09/27/2006CN1837362A SiRNA for inhibiting expression of SARS coronavirus N protein and encoding gene thereof
09/27/2006CN1837213A Bilobalide A derivatives and pharmaceutical application thereof
09/27/2006CN1837212A Bilobalide B derivatives and pharmaceutical application thereof
09/27/2006CN1837207A Pirazino(aza)indole derivatives
09/27/2006CN1836717A Quality controlling method for pulse restoring injection
09/27/2006CN1836697A Candy for larynx
09/27/2006CN1836690A Method for preparing cough-relieving apophlegmatic Mogolian medicine
09/27/2006CN1836682A Gadol drop pills and preparation method thereof
09/27/2006CN1836681A Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method
09/27/2006CN1836673A Chinese medicinal soft capsule and method for preparing and controlling the quality of Chinese medicinal soft capsule
09/27/2006CN1836654A Pharmaceutical composition for stabilizing ambroxol hydrochloride granula
09/27/2006CN1836568A Wild rose health food and preparation method thereof
09/27/2006CN1836533A Herbal health drink and its production method
09/27/2006CN1276911C New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method
09/27/2006CN1276778C SARS nucleic acid vaccine and preparation method
09/27/2006CN1276777C SARS vaccine of adenovirus vector and preparation method, application of coronavirus S gene
09/27/2006CN1276766C Chinese traditional medicine for treating acute laryngopharyngitis and its preparing process
09/27/2006CN1276765C Incense fumigating agent for coryza
09/26/2006US7112654 Ligand for vascular endothelial growth factor receptor
09/26/2006US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders
09/26/2006US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
09/26/2006US7112592 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
09/26/2006US7112589 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
09/26/2006US7112580 3-nitrogen-6, 7-dioxygen steroids and uses related thereto
09/26/2006US7112568 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells
09/26/2006US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
09/26/2006US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents
09/21/2006WO2006099166A1 Crystalline forms of a biphenyl compound
09/21/2006WO2006099165A1 Crystalline forms of a biphenyl compound
09/21/2006WO2006098684A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase.
09/21/2006WO2006098683A1 2-pyridine derivatives as inhibitors of neutrophile elastase
09/21/2006WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
09/21/2006WO2006097534A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
09/21/2006WO2006097456A1 Taste masked dosage form containing roflumilast
09/21/2006WO2006097441A1 Potassium channel modulating agents and their medical use
09/21/2006WO2006097250A1 The combination of anticholinergics and leukotriene recptor antagonists for the treatment of repiratory diseases
09/21/2006WO2006097247A1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
09/21/2006WO2006002422A9 Compounds for immunopotentiation
09/21/2006WO2005084693A8 Extract of hippophae rhamnoides seed
09/21/2006US20060211764 Cell activator, process for producing cell activator and apparatus therefor
09/21/2006US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND
09/21/2006US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease
09/21/2006US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands
09/21/2006US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
09/21/2006US20060210660 Process for preparing an extract from ivy leaves
09/21/2006US20060210550 Angiogenesis inducer
09/21/2006CA2601717A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
09/21/2006CA2601527A1 Potassium channel modulating agents and their medical use
09/21/2006CA2601250A1 Taste masked dosage form containing roflumilast
09/21/2006CA2601137A1 The use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of acute and chronic bronchitis
09/21/2006CA2600507A1 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
09/21/2006CA2600038A1 2-pyridine derivatives as inhibitors of neutrophile elastase
09/21/2006CA2599236A1 Crystalline forms of a biphenyl compound
09/21/2006CA2595791A1 The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
09/20/2006EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1701933A1 Novel compounds
09/20/2006EP1554253A4 Imidazolium cxcr3 inhibitors
09/20/2006EP1494648B1 Powder formulations suitable for inhalation
09/20/2006EP1492513B1 Hfa-suspension formulations containing an anticholinergic
09/20/2006EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors
09/20/2006EP1280897B1 Regulation of nf-at interacting protein nip 45 variant
09/20/2006EP1218049B1 Apparatus for relieving headaches, rhinitis and other common ailments
09/20/2006EP1158970B1 Combinations of formoterol and a tiotropium salt
09/20/2006EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives
09/20/2006CN1835950A Imidazopyridine derivatives
09/20/2006CN1833709A Honey capsule
09/20/2006CN1833690A Toxic counteracting preparation and novel prepn.
09/20/2006CN1833689A Asthma stop preparation and novel prepn.
09/20/2006CN1833666A Herba Andrographitis chewing tablets and prepn. method
09/20/2006CN1833664A Pterigospermin capsules and prodn. method
09/20/2006CN1833652A Sustained release composns preparation of Fudosteine and clarithromycin
09/20/2006CN1833638A Oral preparation compsns. for expectorant
09/20/2006CN1833629A Locally used gel for mouth and nose
09/20/2006CN1276079C Recombination high molecular form mannose binding lectin (MBL), preparing method and application thereof
09/20/2006CN1275978C Oslasodine hydrochloride preparing process
09/20/2006CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
09/20/2006CN1275962C Novel anticholinergic agents that can be used as medicaments and method for the production thereof
09/20/2006CN1275954C Hydroxamic acid derivatives
09/20/2006CN1275917C Glucocorticoid receptor modulators
09/20/2006CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
09/20/2006CN1275646C Nose drops of recombined human interferon alpha 2b and preparing method
09/20/2006CN1275644C Medicinal composition its preparation method and its use in preparing medicine for treating SARS and its complication
09/20/2006CN1275601C Composition and method of tissue superoxygenation
09/20/2006CN1275596C Application of probuco monoester intreating amgiocardiopathy and inflammatry disease
09/20/2006CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
09/19/2006US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/19/2006US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases
09/19/2006US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems
09/19/2006US7109231 Antiinflammatory agents; sepsis
09/19/2006US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
09/19/2006US7109210 substituted with (hetero)aryl carbonyloxy group and quaternized, e.g., 3(R)-Diphenylacetoxy-1-(3-phenoxy-propyl)-1-azoniabicyclo[2.2.2]octane; bromide; antimuscarinic agents for treating COPD, chronic bronchitis, asthma and rhinitis.
09/19/2006US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists
09/19/2006US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases
09/19/2006US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use
09/19/2006US7109176 For therapy of inflammatory diseases and conditions in humans and animals
09/19/2006US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors